ATE354662T1 - Modifizierte hpv e6- und e7-gene und -proteine als impfstoff - Google Patents
Modifizierte hpv e6- und e7-gene und -proteine als impfstoffInfo
- Publication number
- ATE354662T1 ATE354662T1 AT01107271T AT01107271T ATE354662T1 AT E354662 T1 ATE354662 T1 AT E354662T1 AT 01107271 T AT01107271 T AT 01107271T AT 01107271 T AT01107271 T AT 01107271T AT E354662 T1 ATE354662 T1 AT E354662T1
- Authority
- AT
- Austria
- Prior art keywords
- dna sequences
- protein
- vaccine
- genes
- proteins
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 108020004705 Codon Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20010107271 EP1243655B1 (de) | 2001-03-23 | 2001-03-23 | Modifizierte HPV E6- und E7-Gene und -Proteine als Impfstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354662T1 true ATE354662T1 (de) | 2007-03-15 |
Family
ID=8176911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01107271T ATE354662T1 (de) | 2001-03-23 | 2001-03-23 | Modifizierte hpv e6- und e7-gene und -proteine als impfstoff |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7201908B2 (de) |
| EP (1) | EP1243655B1 (de) |
| JP (1) | JP2004531253A (de) |
| AT (1) | ATE354662T1 (de) |
| AU (1) | AU2002312774A1 (de) |
| DE (1) | DE60126737T2 (de) |
| ES (1) | ES2284559T3 (de) |
| MX (1) | MXPA03008559A (de) |
| WO (1) | WO2002081709A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE354662T1 (de) * | 2001-03-23 | 2007-03-15 | Deutsches Krebsforsch | Modifizierte hpv e6- und e7-gene und -proteine als impfstoff |
| BR0309603A (pt) * | 2002-04-24 | 2005-02-15 | Univ Bruxelles | Polipeptìdeo e7 mutado de hpv-16, composição farmacêutica que o compreende e seu processo de preparação |
| CZ297389B6 (cs) * | 2003-07-03 | 2006-11-15 | Ústav Molekulární Biologie Rostlin Av Cr | Fúzní protein pro vakcinaci proti lidskému papillomaviru a zpusob jeho produkce |
| JPWO2005049824A1 (ja) * | 2003-11-21 | 2007-11-29 | 独立行政法人科学技術振興機構 | 生体構造認識部位を提示する中空ナノ粒子およびその生産方法、並びにその利用 |
| EP1708745B1 (de) | 2003-12-23 | 2012-04-18 | Arbor Vita Corporation | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung |
| US20090028874A1 (en) * | 2003-12-24 | 2009-01-29 | Leiden University Medical Center | Synthetic Protein as Tumor-Specific Vaccine |
| KR100755991B1 (ko) | 2005-08-11 | 2007-09-06 | 신정임 | 최적화된 유전자 코돈을 가지는 ｅ7 유전자 및 라이소좀타겟팅 시그널 서열을 포함하는 파필로마바이러스 유발질환의 예방 또는 치료용 조성물 |
| ES2443216T3 (es) * | 2006-04-19 | 2014-02-18 | Postech Academy-Industry Foundation | Proteínas de fusión que comprenden polipéptidos de VPH y péptidos de inmunopotenciación de tratamiento y prevención del cáncer cervicouterino |
| KR20090103571A (ko) * | 2008-03-28 | 2009-10-01 | 바이오코아 주식회사 | 면역성 펩타이드 및 그 펩타이드를 포함하는 ｈｐｖ 관련질환 예방 또는 치료용 조성물 |
| EP2497494B1 (de) * | 2009-11-06 | 2018-01-24 | Chimera Pharma, S. L. U. | Imfpstoffe zur behandlung von neoplasien aus viralen birnavirus-kapsiden mit antigenen des humanen papillomavirus |
| EP2335730A1 (de) | 2009-12-18 | 2011-06-22 | Deutsches Krebsforschungszentrum | Fusionspolypeptide und ihre Verwendung zur Vorbeugung und Behandlung von Krebs |
| PL2604629T3 (pl) | 2010-08-13 | 2018-08-31 | Genexine, Inc. | Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego |
| CN103772508B (zh) * | 2014-01-15 | 2017-05-10 | 深圳泰来生物医药有限公司 | 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗 |
| CA2957128C (en) | 2014-08-15 | 2023-09-26 | Genexine, Inc. | Methods of treating cervical cancer |
| EP3209676A4 (de) * | 2014-10-24 | 2018-03-28 | Hpvvax, Llc | Behandlung von krebs- und hautläsionen |
| KR102895580B1 (ko) * | 2015-12-09 | 2025-12-03 | 진강 메디신 (오스트레일리아) 피티와이 엘티디 | 치료를 위한 면역조절용 조성물 |
| CN111019971A (zh) * | 2019-12-19 | 2020-04-17 | 上海同科生物科技有限公司 | 在rosa26位点条件性过表达hpv e6基因小鼠模型的构建方法 |
| AU2021261676B2 (en) | 2020-04-24 | 2025-04-24 | Genexine, Inc. | Method for treating cervical cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4882145A (en) * | 1986-12-09 | 1989-11-21 | Scripps Clinic And Research Foundation | T cell epitopes of the hepatitis B virus nucleocapsid protein |
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| DE19819476C1 (de) * | 1998-04-30 | 2000-01-05 | Deutsches Krebsforsch | Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins |
| JP4799789B2 (ja) * | 1999-08-25 | 2011-10-26 | メルク・シャープ・エンド・ドーム・コーポレイション | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 |
| US7001995B1 (en) * | 1999-08-25 | 2006-02-21 | Merck & Co., Inc. | Synthetic human papillomavirus genes |
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| ATE354662T1 (de) | 2001-03-23 | 2007-03-15 | Deutsches Krebsforsch | Modifizierte hpv e6- und e7-gene und -proteine als impfstoff |
-
2001
- 2001-03-23 AT AT01107271T patent/ATE354662T1/de not_active IP Right Cessation
- 2001-03-23 DE DE2001626737 patent/DE60126737T2/de not_active Expired - Lifetime
- 2001-03-23 ES ES01107271T patent/ES2284559T3/es not_active Expired - Lifetime
- 2001-03-23 EP EP20010107271 patent/EP1243655B1/de not_active Expired - Lifetime
-
2002
- 2002-03-22 WO PCT/EP2002/003271 patent/WO2002081709A2/en not_active Ceased
- 2002-03-22 MX MXPA03008559A patent/MXPA03008559A/es active IP Right Grant
- 2002-03-22 AU AU2002312774A patent/AU2002312774A1/en not_active Abandoned
- 2002-03-22 US US10/472,724 patent/US7201908B2/en not_active Expired - Fee Related
- 2002-03-22 JP JP2002580072A patent/JP2004531253A/ja active Pending
-
2007
- 2007-04-10 US US11/733,574 patent/US7700114B2/en not_active Expired - Fee Related
- 2007-04-10 US US11/733,654 patent/US20070190074A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1243655B1 (de) | 2007-02-21 |
| DE60126737T2 (de) | 2007-11-08 |
| EP1243655A1 (de) | 2002-09-25 |
| DE60126737D1 (de) | 2007-04-05 |
| ES2284559T3 (es) | 2007-11-16 |
| JP2004531253A (ja) | 2004-10-14 |
| WO2002081709A3 (en) | 2003-03-06 |
| US20070196339A1 (en) | 2007-08-23 |
| WO2002081709A2 (en) | 2002-10-17 |
| US7700114B2 (en) | 2010-04-20 |
| US20040171806A1 (en) | 2004-09-02 |
| US20070190074A1 (en) | 2007-08-16 |
| AU2002312774A1 (en) | 2002-10-21 |
| US7201908B2 (en) | 2007-04-10 |
| MXPA03008559A (es) | 2005-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60126737D1 (de) | Modifizierte HPV E6- und E7-Gene und -Proteine als Impfstoff | |
| CY1112334T1 (el) | Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων | |
| DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
| ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
| MXPA02006888A (es) | Flavivirus recombinantes y metodos para utilizar los mismos. | |
| BRPI0409789A (pt) | vacina de tuberculose com eficácia aperfeiçoada | |
| MX336112B (es) | Vacunas e inmunoterapicos que usan il-15 optimizada de codones y metodos para usar los mismos. | |
| DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| DK1108035T3 (da) | Behandling af cervixcancer | |
| CY1109257T1 (el) | Χιμαιρικες πρωτεϊνες l1 του ιου 16 ανθρωπινων θηλωματων που περιλαμβανουν l2 πεπτιδιο, ομοιαζοντα με ιο σωματιδια που παρασκευαζονται απο αυτες και μεθοδος παρασκευης των σωματιδιων | |
| DK1246917T3 (da) | Humane Stra6-polypeptider | |
| WO2001090326A3 (en) | Novel matrix metalloproteinases | |
| ATE310810T1 (de) | Polypeptid und dafür kodierendes nukeinsäure | |
| ATE325880T1 (de) | Herstellung eines rekombinanten proteins in prokaryotischen wirtszellen durch kodonsoptimisierung | |
| DE602005015368D1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen | |
| CO5580837A2 (es) | Vacuna dna que codifica al menos dos proteinas tempranas no estructurales de papilomavirus | |
| DE60026049D1 (de) | POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN | |
| DE60038986D1 (de) | Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure | |
| DK1241186T3 (da) | Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor | |
| DE60043258D1 (de) | Menschliches suppressor von fused | |
| DE69829230D1 (de) | Polypeptid und dafür kodieredes Nukleinsäure | |
| ATE380864T1 (de) | Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure | |
| ATE291085T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
| PT1277833E (pt) | Gene que e amplificado em tumores e materiais e metodos relacionados | |
| DE69824455D1 (de) | PRO241 Polypeptide und dafür kodierende Nukleinsäuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |